04.04.2013 Views

FORENSIC TOXICOLOGY - Bio Medical Forensics

FORENSIC TOXICOLOGY - Bio Medical Forensics

FORENSIC TOXICOLOGY - Bio Medical Forensics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Celebrating<br />

60 years<br />

K1 Gas Chromatography of Postmortem<br />

Blood Revealing Sevoflurane in a<br />

Patient Six Hours Post-Op<br />

Diane C. Peterson, MD*, and Susan Kloda, MT, University of Alabama at<br />

Birmingham, Department of Pathology, 619 South 19th Street,<br />

Birmingham, AL 35233; Gary T. Simmons, MD, and Robert M. Brissie,<br />

MD, Jefferson County <strong>Medical</strong> Examiner’s Office, 1515 South 6th Avenue,<br />

Birmingham, AL 35233; and C. Andrew Robinson, PhD, University of<br />

Alabama, Department of Pathology, 619 South 19th Street, Birmingham,<br />

AL 35233<br />

Attendees will understand basic physiology and properties of sevoflurane,<br />

a general anesthetic used in same-day surgeries. Attendees will also<br />

learn that sevoflurane may interfere with an ethanol peak with a certain<br />

method of gas chromatography.<br />

This poster will impact the forensic science community by alerting the<br />

community to the possibility of the presence of “ethanol” peaks on gas<br />

chromatography due to sevoflurane in post-operative patients.<br />

A 54-year-old female patient underwent facelift surgery which lasted<br />

approximately six hours. During surgery, sevoflurane was used for induction<br />

and maintenance of anesthesia. There were no intraoperative complications.<br />

The patient was discharged home about one hour and forty-five minutes postop<br />

at 1645 hours. Her only post-op complaint was of a migraine headache,<br />

which was treated with topiramate (Topamax®). Patient history as detailed<br />

by her family, stated that the patient consumed only ginger ale and yogurt<br />

prior to going to sleep after surgery. At 2100 hours, she was sleeping soundly.<br />

At 2115 hours, she was not breathing and unresponsive. Postmortem examination<br />

revealed focal moderate calcific atherosclerotic narrowing of the<br />

proximal left anterior descending coronary artery, microscopic fibrosis of<br />

the superior interventricular septum of the heart near the atrioventricular<br />

node, and mild to moderate microvesicular steatosis of the liver. Postmortem<br />

toxicology revealed the presence of citalopram (Celexa®), lidocaine, morphine,<br />

and fentanyl. Gas chromatography (GC) of postmortem blood revealed<br />

a peak at 2.496 seconds retention time, consistent with ethanol<br />

(retention time 2.3 ± 0.1 sec). The concentration of ethanol was calculated<br />

to be 0.05 g/dL. Antemortem blood also revealed ethanol by GC at a<br />

concentration of 0.04 g/dL. However, the vitreous fluid was negative for<br />

ethanol.<br />

Due to the family’s insistence that the patient had not consumed ethanol,<br />

possible interferences were sought. Of the medications the patient received,<br />

sevoflurane was the best possible medication to cause interference. Sevoflurane<br />

[fluoromethyl 2,2,2,-trifluoro-1-(trifluoromethyl) ethyl ether] is a four<br />

carbon molecule that exists as a liquid and is used for induction and maintenance<br />

of anesthesia. A review of the literature revealed two manuscripts<br />

which reported ethanol and sevoflurane peaks to be within 0.1 and 0.15<br />

seconds of each other (<strong>Bio</strong>med Chromatogr 2004; 18: 714-18 and Clin<br />

Chem 2001; 47: 281-91, respectively). Ethanol-negative blood was spiked<br />

with varying dilutions of sevoflurane, which co-eluted with ethanol. For<br />

example, the retention time of the 1:20,000 dilution was 2.483 seconds.<br />

Volatile analysis was performed with a head space procedure, using<br />

n-propanol as the internal standard. The column was a 6 foot Porapak-S at<br />

a temperature of 180°C. Instrumentation was Shimadzu GC-I 4A, Kyoto,<br />

Japan. Due to the high volatility of sevoflurane, a linear concentration curve<br />

could not be produced.<br />

A study by Kharasch et al. of sevoflurane’s metabolism and pharmacokinetics<br />

shows that it can still be detected in a patient’s blood several hours<br />

after an administration of three to five hours (Anesthesiology 1995; 82:<br />

1369-78). The average half-life of sevoflurane in that study was 2.8 ± 1.0<br />

hours. The above patient died approximately six hours after the end of<br />

<strong>TOXICOLOGY</strong><br />

1948 ~ 2008<br />

anesthetic administration. The long detection time may be partially due to<br />

the high partition coefficient for adipose tissue. Adipose tissue dominates the<br />

pharmacokinetics past three hours post-administration (BMC Clin Pharmacol<br />

2007; 7:1-21). The above patient had a body mass index of 28.6 kg/m2 ,<br />

indicating a possible increase in body fat percentage over normal.<br />

Therefore, although ethanol cannot be completely excluded, it is likely<br />

that the above patient did have sevoflurane in her blood, causing an interfering<br />

peak on gas chromatography. An interfering peak was obtained when<br />

ethanol-negative blood was spiked with sevoflurane. However, due to the<br />

high volatility of sevoflurane, consistent data points could not be obtained to<br />

determine the concentration of sevoflurane in the patient’s blood.<br />

Gas Chromatography, Sevoflurane, Ethanol<br />

K2 Signature Analysis of 25 Illicit Cocaine<br />

Samples and a Comparison to Analysis<br />

by AccuTOF DART<br />

Jeri D. Ropero-Miller, PhD*, Peter R. Stout, PhD, Edward J. Minden<br />

Jr., BS, and Nichole D. Bynum, MS, RTI International, Center for Forensic<br />

Sciences, 3040 Cornwallis Road, Building 3, Research Triangle Park, NC<br />

27709; John F. Casale, BS, Drug Enforcement Administration, Special<br />

Testing Laboratory, 22624 Dulles Summit Court, Dulles, VA 20166;<br />

Insook Kim, PhD, Jennifer Runkle, BS, Marilyn Past, PhD, and Buddha D.<br />

Paul, PhD, Armed Forces Institute of Pathology, 1413 Research<br />

Boulevard, Building 102, Rockville, MD 20850<br />

After attending this presentation, attendees will gain an enhanced<br />

understanding of multiple techniques for characterization of illicit cocaine<br />

and their ability to assess purity, level of performance, and their ability to<br />

determine specific compounds of interest.<br />

This presentation will impact the forensic science community by<br />

providing a comparison of established quantitative, chromatographic method<br />

to a novel qualitative time-of flight mass spectrometric method to determine<br />

the purity of illicit cocaine and its relative abundance of signature<br />

compounds.<br />

Introduction: Characterization of 25 illicit cocaine samples was<br />

undertaken in support of a research project funded in part by the National<br />

Institute of Justice (NIJ Award # 2006-DN-BX-K019) examining the ratios<br />

of cocaine-related compounds in hair samples contaminated with cocaine.<br />

Various coca-related compounds, isotope ratios and solvent determinations<br />

among other parameters are used to determine the manufacturing process<br />

and geographical origin of cocaine exhibits. Furthermore, this information<br />

is a useful tool to answer questions related to cocaine distribution and<br />

trafficking.<br />

A novel application of direct analysis in real time (DART) sample<br />

introduction coupled with time-of-flight (TOF) mass spectrometry was<br />

evaluated for analyzing 25 samples of bulk powdered illicit cocaine hydrochloride<br />

salt seized by the Drug Enforcement Administration (DEA). The<br />

cocaine samples were analyzed by the DEA to determine their “signature”<br />

including their purity and the presence of specific compounds including<br />

products of manufacture, adulterants, and other cocaine analytes including<br />

oxidation products. The results of the analysis were then compared to data<br />

obtained by CFS to assess the AccuTOF-DART’s level of performance.<br />

Methods: Analysis was conducted in positive mode using AccuTOF-<br />

DART mass spectrometry. After analysis of the cocaine samples, each data<br />

set was examined for the presence of cocaine analytes (e.g., cocaine,<br />

benzoylecgonine, ecgonine ethyl ester, cocaethylene, norcocaine,<br />

anhydroecgonine methyl ester, truxillines, other ethyl esters) and a number<br />

87 * Presenting Author

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!